Reaction Details Report a problem with these data
Target
Dual specificity protein kinase CLK2
Ligand
BDBM317462
Substrate
n/a
Meas. Tech.
ChEBML_1681479
IC50
6.0±n/a nM
Citation
 Riggs, JR; Nagy, M; Elsner, J; Erdman, P; Cashion, D; Robinson, D; Harris, R; Huang, D; Tehrani, L; Deyanat-Yazdi, G; Narla, RK; Peng, X; Tran, T; Barnes, L; Miller, T; Katz, J; Tang, Y; Chen, M; Moghaddam, MF; Bahmanyar, S; Pagarigan, B; Delker, S; LeBrun, L; Chamberlain, PP; Calabrese, A; Canan, SS; Leftheris, K; Zhu, D; Boylan, JF The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen. J Med Chem 60:8989-9002 (2017) [PubMed]  Article 
Target
Name:
Dual specificity protein kinase CLK2
Synonyms:
2.7.12.1 | CDC-like kinase 2 | CDC-like kinase 2 (CLK2) | CDC2-like kinase 2 (CLK2) | CLK2 | CLK2_HUMAN
Type:
n/a
Mol. Mass.:
60128.79
Organism:
Homo sapiens (Human)
Description:
P49760
Residue:
499
Sequence:
MPHPRRYHSSERGSRGSYREHYRSRKHKRRRSRSWSSSSDRTRRRRREDSYHVRSRSSYDDRSSDRRVYDRRYCGSYRRNDYSRDRGDAYYDTDYRHSYEYQRENSSYRSQRSSRRKHRRRRRRSRTFSRSSSQHSSRRAKSVEDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSRDISR
  
Inhibitor
Name:
BDBM317462
Synonyms:
4-(4-(cyclopentyloxy)-5-(2- methylbenzo[d]oxazol-6-yl)-7H- pyrrolo[2,3-d]pyrimidin-2- ylamino)-3-methoxy-N- methylbenzamide | US9623028, Compound 38
Type:
Small organic molecule
Emp. Form.:
C28H28N6O4
Mol. Mass.:
512.5597
SMILES:
CNC(=O)c1ccc(Nc2nc(OC3CCCC3)c3c(c[nH]c3n2)-c2ccc3nc(C)oc3c2)c(OC)c1
Structure:
Search PDB for entries with ligand similarity: